Urinary incontinence secondary to carvedilol

Authors

  • João Porto Médico do Internato Complementar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • José Manuel Silva Assistente Hospitalar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • M. B. Alexandrino Chefe de Serviço de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • J. J. Alves de Moura Chefe de Serviço de Medicina Interna e Director do Serviço de Medicina II dos Hospitais da Universidade de Coimbra

Keywords:

beta-blocker, carvedilol, urinary incontinence

Abstract

We present a clinical case-report of a 59-years old woman, with essential hypertension, who
had stress urinary incontinence after taking
carvedilol. This beta-adrenergic antagonist, often used in clinical practice, can cause this secondary effect because of its antagonist action on alpha1-receptors of the urinary tract, which causes relaxation of the urethral sphincter.

Downloads

Download data is not yet available.

References

Hieble JP, Ruffolo RR Jr.. Recent advances in the identification of -1 and -2 adrenoreceptor subtypes: therapeutic implications. Exp. Opin.

Invest. Drugs 1997; 6 (4): 367-387.

Cruickshank JM. Beta-blockers continue to surprise us. European Heart Journal 2000; 21: 354-364.

Cheng J, Kamiya K, Kodama I. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potencial. Cardiovasc. Drug Rev

; 19 (2): 152-171.

Cleland JG. Progression from hipertension to heart failure: mechanisms management. Cardiology 1999; 92 (1): 10-19.

Ruffolo RR, Hieble JP. The adrenoreceptors: historical perspectives, current status and future directions. Pharmacology communications

; 6(1-3) : 1-7.

Carruthers SG. Adverse effects of alpha-1-adrenergic blocking drugs. Drug Saf 1994; 11 (1): 12-20.

Menefer AS, Chesson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting

enzyme inhibitors. Obstet Gynecol 1998; 91 (2): 853-854.

Dwyer PL, Teele JS. Prazosin: a neglected cause of genuine stress incontinence. Obstet Gynecol 1992 ; 79 (1): 117-121.

Marshal HJ, Beevers DG. Alpha-adrenoreceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Br J Clin

Pharmacol 1996; 42 (4): 507-509

Sullivan J, Abrams P. Pharmacological management of incontinence. Eur Urol 1999; 36 (1): 89-95.

Ruffolo RR Jr, Hieble JP. Adrenoreceptor pharmacology: urogenital applications. Eur Urol 1999; 36 (1): 17-22.

Hemaly AK, Mousa LA. Stress urinary incontinence, a new concept. Eur J Obstet Gynecol Reprod iol 1996 ; 68 (1-2): 129-135

Additional Files

Published

2003-06-30

How to Cite

1.
Porto J, Silva JM, Alexandrino MB, Alves de Moura JJ. Urinary incontinence secondary to carvedilol. RPMI [Internet]. 2003 Jun. 30 [cited 2024 Dec. 18];10(2):87-90. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1802

Issue

Vol. 10 No. 2 (2003): Abril/ Junho

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)

1 2 > >>